Digital Pathology & Imaging - software & AI news

Daily news on software, AI, and companies shaping digital pathology & imaging.

Showing 103 results
A minimalist illustration of a stethoscope and brain representing AI in diagnostics.

Apr 29, 2026

Why Medtech Giants Are Quietly Paying Up for AI Diagnostics

The escalating demand for AI diagnostics in the medtech sector is driving significant mergers and acquisitions, with companies increasingly prioritizing AI-enabled platforms that demonstrate clinical validation.The market for AI in medical imaging is projected to reach $2.20 billion by 2026, showcasing a remarkable growth rate of 34.8% through 2033. This trend is mirrored in recent healthcare M&A activities, where investment is flowing toward AI platforms that have regulatory approval and establ
A flat illustration of a dermatoscope on a solid background.

Apr 29, 2026

European HealthTech Is Using AI To Catch Cancer Earlier – And Investors Are Starting To Pay Attention

European startups are harnessing artificial intelligence (AI) to improve early cancer detection, drawing increased interest from investors.Traditionally, late cancer diagnosis has significantly impacted survival rates, but a new wave of AI-driven solutions aims to change that narrative. Notably, Paris-based SquareMind recently secured $18 million in funding, indicating investor confidence in AI diagnostics. Their innovative Swan robot captures standardized, full-body dermoscopic images quickly,
A minimalist representation of a pill and a molecule, symbolizing AI-bio partnerships.

Apr 29, 2026

AstraZeneca Korea spotlights AI-bio partnerships at BIO KOREA 2026

AstraZeneca Korea is actively engaging in the AI-bio landscape, showcasing its collaborations at BIO KOREA 2026, the country’s premier bio-health convention.During the Open Innovation session, Nick Passey, AstraZeneca's Head of International Commercial, Digital & IT Strategy, highlighted the company's commitment to enhancing Korea's AI-bio ecosystem. His presentation focused on the theme of accelerating drug development through AI-based open innovation, emphasizing AstraZeneca's collaborative ef
A pregnant woman in a clinical setting with an ultrasound device.

Apr 28, 2026

Qure.ai Partners with THSTI to Develop AI-enabled Ultrasound Tools for Preterm Birth Risk Detection

Qure.ai has announced a collaboration with the Translational Health Science and Technology Institute (THSTI) to enhance maternal healthcare through AI-enabled ultrasound technology, focusing specifically on preterm birth risk detection.This partnership is part of the GARBH-INi-AnandiMaa initiative, which aims to improve preterm birth outcomes in India, a country that faces significant challenges related to neonatal mortality and long-term health issues stemming from preterm births. The initiativ
MRI machine in a hospital imaging room with a patient and technician

Apr 27, 2026

Medical Imaging Market Advances with AI-Powered Diagnostics and Forecast Growth to 2033

The medical imaging market is experiencing significant growth, driven by advancements in AI-powered diagnostics and increasing healthcare investments.The integration of artificial intelligence into medical imaging is revolutionizing the field, enhancing diagnostic accuracy and improving patient outcomes. A recent report indicates that the global medical imaging market, valued at approximately USD 42.6 billion in 2024, is projected to grow to USD 70.16 billion by 2033, reflecting a compound annua
A robotic skin imaging device next to a patient's arm in a clinical setting.

Apr 27, 2026

Squaremind raises $18 million to redefine skin exams with robotics and AI

SquareMind, a company focused on AI and robotics in dermatology, has secured $18 million in funding to enhance the quality and accessibility of skin exams through its innovative technology.The funding round, led by Sonder Capital and supported by various investors, will enable SquareMind to expand its teams and prepare for the upcoming launch of the Swan robotic skin imaging platform in the U.S. and Europe. This initiative comes in response to an increasing demand for skin exams, driven by an ag
Minimalist illustration of a transseptal access device and neurovascular imaging scan

Apr 25, 2026

Johnson And Johnson Expands MedTech And Brain Health With Atraverse And Viz.ai

Johnson & Johnson is making significant strides in its MedTech and brain health sectors through the acquisition of Atraverse Medical and a partnership with Viz.ai.The acquisition of Atraverse Medical enhances J&J's portfolio with transseptal access solutions aimed at minimally invasive cardiac procedures. Meanwhile, the collaboration with Viz.ai focuses on integrating AI-driven neurovascular imaging into J&J's MedTech offerings. These strategic moves aim to bolster J&J's capabilities in both car